Chronic treatment with bromocriptine modifies metabolic adjustments in response to restraint stress in rats

Autonomic and Autacoid Pharmacology

Volumn 27, Issue 2, 2007, Pages 123-129

  Balthazar, C H ^a   Ribeiro Oliveira Jr , A ^a   Marubayashi, U ^a   Dos Reis, A M ^a   Coimbra, C C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bromocriptine; Free fatty acids; Glucose; Lactate; Restraint stress

Indexed keywords

BROMOCRIPTINE; FATTY ACID; GLUCOSE; LACTIC ACID; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BASAL METABOLIC RATE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENERGY METABOLISM; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROWTH; HOMEOSTASIS; HYPERGLYCEMIA; IMMOBILIZATION STRESS; LACTATE BLOOD LEVEL; MALE; NONHUMAN; RAT;

ANIMALS; BLOOD GLUCOSE; BROMOCRIPTINE; DOPAMINE AGONISTS; FATTY ACIDS, NONESTERIFIED; LACTATES; MALE; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; STRESS;

EID: 33947689633     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2007.00398.x     Document Type: Article

References (49)

1. ACHTEN, J. & JEUKENDRUP, A.E. (2004). Relation between plasma lactate concentration and fat oxidation rates over a wide range of exercise intensities. Int. J. Sports Med., 25, 32-37.
2. ARNERIC, S.P., CHOW, S.A., BHATNAGAR, R.K., WEBB, R.L., FISCHER, L.J. & LONG, J.P. (1984a). Evidence that central dopamine receptors modulate sympathetic neuronal activity to the adrenal medulla to alter glucoregulatory mechanisms. Neuropharmacology, 23 (2A), 137-147.
3. ARNERIC, S.P., CHOW, S.A., LONG, J.P. & FISCHER, L.J. (1984b). Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas. J. Pharmacol. Exp. Ther., 228, 551-559.
4. BROOKS, G.A. (1998). Mammalian fuel utilization during sustained exercise. Comp. Biochem. Physiol. B Biochem. Mol. Biol., 120, 89-107.
5. BROOKS, G.A. & MERCIER, J. (1994). Balance of carboydrate and lipid utilization during exercise: the 'crossover' concept. J. Appl. Physiol., 76, 2253-2261.
6. DE FEO, P., DI LORETO, C., LUCIDI, P., MURDOLO, G., PARLANTI, N., DE CICCO, A., PICCIONI, F. & SANTEUSANIO, F.J. (2003). Metabolic response to exercise. J. Endocrinol. Invest., 26, 851-854.
7. DE PERGOLA, G., CIGNARELLI, M., NARDELLI, G., GARRUTI, G., CORSO, M., DI PAOLO, S., CARDONE, F. & GIORGINO, R. (1989). Influence of lactate on isoproterenol-induced lipolysis and beta-adrenoceptors distribution in human fat cells. Horm. Metab. Res., 21, 210-213.
8. DOLE, V.P. & MEINERTZ, H. (1960). Microdetermination of long chain fatty acids in plasma and tissues. J. Biol. Chem., 235, 2595.
9. FITTS, R.H. (2003). Mechanisms of muscular fatigue. In: Principles of Exercise Biochemistry. 3rd edn (ed. J.R. POORTMANS), pp. 279-300. Karger, Basel.
10. FRANCHI, F., LAZZERI, C., BARLETTA, G., IANNI, L. & MANNELLI, M. (2001). Centrally mediated effects of bromocriptine on cardiac sympathovagal balance. Hypertension, 38, 123-129.
11. FRIIS, M.L., PAULSON, O.B. & HERTZ, M.M. (1979). Transfer of bromocriptine across the blood-brain barrier in man. Acta Neurol. Scand., 59, 88-95.
12. GINGRICH, J.A. & CARON, M.G. (1993). Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci., 16, 299-321.
13. GIUDICELLI, Y., JANVIER, B., NORDMANN, J. & NORDMANN, R. (1976). Inhibition of free fatty acid release from isolated rat epididymal fat cells by some natural occurring organic acids. Biomedicine, 30, 25, 376-381.
14. GLADDEN, L.B. (2004). Lactate metabolism: a new paradigm for the third millennium. J. Physiol. 1 558(Pt 1), 5-30.
15. GOLDSTEIN, M., LIEBERMAN, A., BATTISTA, A.F., LEW, J.F. & HATA, F. (1978). Bromocriptine, lergotrile: the anti-parkinsonian efficacy and the interaction with monoaminergic receptors. Pharmacology, 16, 143-149.
16. GORSKI, J. (1977). Effect of lactate on FFA release and cyclic 3′, 5′ AMP accumulation in fat cells at different pH. Acta Physiol. Pol., 28, 505-510.
17. GREENSPAN, F.S. & GARDNER, D.G. (2004). Basic & Clinical Endocrinology, 7th edn. McGraw-Hill, New York.
18. JACKSON, D.M., MOHELL, N., GEORGIEV, J., BENGTSSON, A., LARSSON, L.G., MAGNUSSON, O. & ROSS, S.B. (1995). Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies. Naunyn Schmiedebergs Arch. Pharmacol., 351, 146-155.
19. JAFEE, C.A. & BARKAN, A.L. (1992). Treatment of acromegaly with dopamine agonists. Endocrinol. Metab. Clin. North Am., 21, 713-735.
20. KEBABIAN, J.W. & CALNE, D.B. (1979). Multiple receptors for dopamine. Nature, 277, 93-96.
21. KONDO, T. (2001). Treatment of Parkinson's disease in Japan. Parkinsonism Relat. Disord., 7, 71-77.
22. KUJACIC, M. & CARLSSON, A. (1993). Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors. J. Neural. Transm., 92, 73-79.
23. KUJACIC, M., SVENSSON, K., LOFBERG, L. & CARLSSON, A. (1990). Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonists. Eur. J. Pharmacol. 27, 177, 163-170.
24. KUJACIC, M., SVENSSON, K., LOFBERG, L. & CARLSSON, A. (1991). Dopamine receptors, controlling dopamine levels in rat adrenal glands - comparison with central dopaminergic autoreceptors. J. Neural. Transm., 84, 195-209.
25. KUJACIC, M., HANSSON, L.O. & CARLSSON, A. (1995). Acute dopaminergic influence on plasma adrenaline levels in the rat. Eur. J. Pharmacol. 6, 273, 247-257.
26. KVETNANSKY, R., GOLDSTEIN, D.S., WEISE, V.K., HOLMES, C., SZEMEREDI, K., BAGDY, G. & KOPIN, I.J. (1992). Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats. J. Neurochem., 58, 2296-2302.
27. LAHLOU, S., DUARTE, G.P. & DEMENGE, P. (1993). Central dopaminergic origin of bromocriptine induced tachycardia in normotensive rats. Cardiovasc. Res., 27, 2022-2027.
28. LAHLOU, S., ARAUJO LIMA, P.F., INTERAMINENSE, L.F. & DUARTE, G.P. (2003). Blunted central bromocriptine-induced tachycardia in conscious, malnourished rats. Pharmacol. Toxicol., 92, 189-194.
29. LANGFORT, J., ZARZECZNY, R., PILIS, W., KACIUBA-USCILKO, H., NAZAR, K. & PORTA, S. (1996). Effect of sustained hyperadrenalinemia on exercise performance and lactate threshold in rats. Comp. Biochem. Physiol. A Physiol., 114A, 51-55.
30. van LOON, L.J., THOMASON-HUGHES, M., CONSTANTIN-TEODOSIU, D., KOOPMAN, R., GREENHAFF, P.L., HARDIE, D.G., KEIZER, H.A., SARIS, W.H. & WAGENMAKERS, A.J. (2005). Inhibition of adipose tissue lipolysis increases intra-muscular lipid and glycogen use in vivo in humans. Am. J. Physiol. Endocrinol. Metab., 289, E482-493.
31. MACHADO, L.J., MARUBAYASHI, U., REIS, A.M. & COIMBRA, C.C. (1995a). Effect of [1-Sar,8-Thr]-angiotensin II on the hyperglycemic response to hemorrhage in adreno-demedullated and guanethidine-treated rats. Regul. Pept., 7, 60, 69-77.
32. MACHADO, L.J., MIHESSEN-NETO, I., MARUBAYASHI, U., REIS, A.M. & COIMBRA, C.C. (1995b). Hyperglycemic action of angiotensin II in freely moving rats. Peptides, 16, 479-483.
33. NAGAHAMA, S., CHEN, Y.F. & OPARIL, S. (1984). Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat. J. Pharmacol. Exp. Ther., 228, 370-375.
34. NAGAHAMA, S., CHEN, Y.F., LINDHEIMER, M.D. & OPARIL, S. (1986). Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat. J. Pharmacol. Exp. Ther., 236, 735-742.
35. PIJL, H. & EDO, A.M. (2002). Modulation of monoaminergic neural circuits: potencial for the treatment of type 2 diabetes mellitus. Treat. Endocrinol., 1, 71-78.
36. PILIS, W., ZARZECZNY, R., LANGFORT, J., KACIUBA-USCILKO, H., NAZAR, K. & WOJTYNA, J. (1993). Anaerobic threshold in rats. Comp. Biochem. Physiol. Comp. Physiol., 102A, 285-289.
37. QUIK, M. & SOURKES, T.L. (1977). Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase. J. Neurochem., 28, 137-147.
38. RASCOL, O., GOETZ, C., KOLLER, W., POEWE, W. & SAMPAIO, C. (2002). Treatment interventions for Parkinson's disease: an evidence based assessment. Lancet, 359, 1589-1598.
39. REGUNATHAN, S., MISSALA, K. & SOURKES, T.L. (1989). Central regulation of adrenal tyrosine hydroxylase: effect of induction on catecholamine levels in the adrenal medulla and plasma. J. Neurochem., 53, 1706-1710.
40. REIS, F.M., RIBEIRO DE OLIVEIRA, A. Jr, MACHADO, L.J.C., GUERRA, R.M., REIS, A.M. & COIMBRA, C.C. (1998). Plasma prolactin and glucose alterations induced by surgical stress: a single or dual response? Exp. Physiol., 83, 1-10.
41. RIBEIRO DE OLIVEIRA, A. Jr, GUERRA, R.M., FÓSCOLO, R.B., MARUBAYASHI, U., REIS, A.M. & COIMBRA, C.C. (1999). Effects of chronic bromocriptine (CB-154) treatment on the plasma glucose and insulin secretion response to neurocytoglucopenia in rats. J. Endocrinol., 162, 237-242.
42. RIBEIRO DE OLIVEIRA, A. Jr, GUERRA, R.M., FÓSCOLO, R.B., MARUBAYASHI, U., REIS, A.M. & COIMBRA, C.C. (2001). Bromocriptine-induced dissociation of hyperglycemia and prolactin response to restraint. Pharmacol. Biochem. Behav., 68, 229-233.
43. RIBEIRO OLIVEIRA, A. Jr, BOTION, L.M., GUERRA, R.M., FÓSCOLO, R.B., MACHADO, L.J.C., MARUBAYASHI, U., REIS, A.M. & COIMBRA, C.C. (2003). Acute metabolic effects of thiopental anesthesia on fed and fasted rats chronically treated with bromocriptine. J. Pharmacol. Sci., 92, 149-152.
44. SAHLIN, K., HARRIS, R.C., NYLIND, B. & HULTMAN, E. (1976). Lactate content and pH in muscle obtained after dynamic exercise. Pflugers Arch., 28, 367, 143-149.
45. SALLER, C.F. & KREAMER, L.D. (1991). Glucose concentrations in brain and blood: regulation by dopamine receptor subtypes. Brain Res., 19, 546, 235-240.
46. SCHMIDT, M.J., ROOT, M.A. & HALL, J.L. (1983). Dopamine agonist-induced hyperglycemia in rats: structure-activity relationships and mechanisms of action. Eur. J. Pharmacol., 3, 90, 169-177.
47. SILVEIRA, S.A., HAIBARA, A.S., LIMA, N.V.R. & COIMBRA, C.C. (2003). The hypothalamic paraventricular nucleus and carotid receptors modulate hyperglycemia induced by hemorrhage. Brain Res., 993, 183-191.
48. SILVEIRA, S.A., HAIBARA, A.S. & COIMBRA, C.C. (2005). Hyperglycemic response to hemorrhage is modulated by baroreceptors unloading but not by peripheral chemoreceptors activation. Auton. Neurosci., 123, 36-43.
49. THORNER, M.O., FLÜCKIGER, E. & CALNE, D.B. (1980). Bromocriptine: Clinical and Pharmacological Review. pp. 14-55. Raven Press.